In May 2026, the Central Drugs Standard Control Organisation (CDSCO) issued amended guidelines for Form 27 (application for renewal of manufacturing licence) effective immediately. The revision introduces mandatory third-party facility audits, stricter documentation of quality-control systems, and a compressed 30-day approval window.
For manufacturers across formulations, biologics, and APIs, this marks a material shift in renewal burden and timeline management.
Market signals
CDSCO now requires all Form 27 applicants to submit independent audit reports from CDSCO-accredited auditors before submission. This eliminates self-certification and adds ₹2–5 lakh to renewal costs but accelerates post-filing approval.
The revised SOP compresses the approval timeline from 90 to 30 days, but only if complete documentation—including audit, updated SOPs, and stability data—is filed upfront. Incomplete submissions restart the clock.
Form 27 now explicitly requires certified copies of in-house QC SOP updates, test reports from the preceding 12 months, and validated analytical method records. This closes loopholes in compliance verification.
Manufacturers must align their licence-renewal cycles with the new audit timeline: engage CDSCO-accredited auditors 60–90 days before licence expiry, not at renewal filing. The compressed approval window penalises late or incomplete submissions with rejection and statutory delay. GST liability on audit fees is also clarified (exempt service, no ITC). Vinayakam Consultants helps manufacturers map their renewal schedules, source and coordinate accredited auditors, and pre-audit their QC and SOP records to prevent rejection and maintain uninterrupted licence validity.
Your action checklist
- Identify your licence expiry date and book CDSCO-accredited audit firm 90 days prior; confirm auditor's current accreditation status on CDSCO website.
- Conduct internal QC audit: compile 12-month test reports, updated SOPs, stability data, and method validation certificates in CDSCO-prescribed format.
- Prepare Form 27 with revised checklist: attach third-party audit report, certification of no adverse effects/complaints, and updated facility layout with labelled critical areas.
- File Form 27 + audit report + supporting documents as a complete bundle; track submission date and request acknowledgment to ensure 30-day clock starts and avoids restart risk.
Frequently asked questions
From June 2026, manufacturers must submit independent CDSCO-accredited audit reports, certified QC SOPs, and 12-month test records. The approval timeline is compressed to 30 days if documentation is complete.
Engage CDSCO-accredited auditors 60–90 days before licence expiry to allow time for the third-party audit and documentation preparation before filing.
Incomplete submissions restart the 30-day approval clock, risking statutory delay and licence rejection. Early engagement with auditors prevents this penalty.